Cite
HARVARD Citation
Tolaney, S. et al. (2017). Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients. Oncologist. pp. 25-32. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tolaney, S. et al. (2017). Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients. Oncologist. pp. 25-32. [Online].